Nabriva Faces Skepticism After Years Of Preparing For Novel Antibiotic Xenleta's Launch

 
• By Mandy Jackson
sales manager giving advice to his couple clients
Nabriva profiled customers based on CABP treatment priorities, seeking a differentiated Xentela launch approach. • Source: Shutterstock

More from Anti-infective

More from Therapeutic Category